000 | 01203 a2200349 4500 | ||
---|---|---|---|
005 | 20250512005111.0 | ||
264 | 0 | _c19890919 | |
008 | 198909s 0 0 eng d | ||
022 | _a0770-3198 | ||
024 | 7 |
_a10.1007/BF02030079 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Rooij, D J | |
245 | 0 | 0 |
_aMarker antibodies in scleroderma and polymyositis: clinical associations. _h[electronic resource] |
260 |
_bClinical rheumatology _cJun 1989 |
||
300 |
_a231-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAntibody Specificity |
650 | 0 | 4 |
_aAutoantibodies _xanalysis |
650 | 0 | 4 |
_aCentromere _ximmunology |
650 | 0 | 4 |
_aDNA Topoisomerases, Type I _ximmunology |
650 | 0 | 4 |
_aDermatomyositis _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoblotting |
650 | 0 | 4 |
_aMyositis _ximmunology |
650 | 0 | 4 |
_aScleroderma, Systemic _xclassification |
650 | 0 | 4 | _aSyndrome |
700 | 1 | _aVan de Putte, L B | |
700 | 1 | _aHabets, W J | |
700 | 1 | _aVan Venrooij, W J | |
773 | 0 |
_tClinical rheumatology _gvol. 8 _gno. 2 _gp. 231-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02030079 _zAvailable from publisher's website |
999 |
_c2553501 _d2553501 |